Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.71 USD
Change Today -0.10 / -1.72%
Volume 1.2M
ARRY On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 2:07 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for array biopharma inc (ARRY)

Year over year, Array BioPharma Inc. has seen revenues fall from $69.6M USD to $42.1M USD. This along with an increase in the cost of goods sold expense has led to a reduction in the bottom line from a loss of $61.9M USD to an even larger loss of $85.3M USD.
Currency in
Millions of US Dollars
As of:Jun 30
2011
Restated
Jun 30
2012
Jun 30
2013
Jun 30
2014
4 Year
Trend
Revenues71.985.169.642.1
TOTAL REVENUES71.985.169.642.1
Cost of Goods Sold27.324.330.146.0
GROSS PROFIT44.660.939.5-3.9
Selling General & Admin Expenses, Total16.015.219.621.3
R&D Expenses59.956.759.447.6
OTHER OPERATING EXPENSES, TOTAL75.871.979.068.9
OPERATING INCOME-31.2-11.0-39.5-72.8
Interest Expense-15.5-11.6-11.3-9.7
Interest and Investment Income0.40.00.10.1
NET INTEREST EXPENSE-15.1-11.6-11.2-9.6
EBT, EXCLUDING UNUSUAL ITEMS-46.3-22.6-50.7-82.5
Merger & Restructuring Charges-5.5-----2.8
Gain (Loss) on Sale of Investments1.9------
Other Unusual Items, Total-6.3-0.9-11.2--
Other Unusual Items-6.3-0.9-11.2--
EBT, INCLUDING UNUSUAL ITEMS-56.3-23.6-61.9-85.3
Earnings from Continuing Operations-56.3-23.6-61.9-85.3
NET INCOME-56.3-23.6-61.9-85.3
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-56.3-23.6-61.9-85.3
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-56.3-23.6-61.9-85.3
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARRY:US $5.71 USD -0.10

ARRY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $4.02 USD -0.02
CTI BioPharma Corp $1.83 USD -0.02
Evotec AG €3.50 EUR +0.12
Exelixis Inc $5.97 USD +0.24
Progenics Pharmaceuticals Inc $8.58 USD -0.08
View Industry Companies
 

Industry Analysis

ARRY

Industry Average

Valuation ARRY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.8x
Price/Book 16.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARRAY BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.